Skip to main content

Clinical Trials › NCT05134441

Active, Not RecruitingPhase 3

Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

Sponsored by Immunic AG

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
1121
Target enrollment
4
U.S. states
Nov 2021
Start date
Sep 2033
Expected completion

Interventions / Treatments

IMU-838 tabletsPlacebo matching IMU-838 tablets

Conditions studied

Multiple Sclerosis

Where this trial is running (6 sites)

Florida3 sites
Bradenton · Naples · Ormond Beach
Arizona1 site
Phoenix
West Hollywood
Illinois1 site
Northbrook

Participating MS centers on MS Buddy (3)

MS centers in Florida

Compare treatment centers near a trial site by center type, providers and trials.

View Florida centers

More Phase 3 trials

Browse all Phase 3 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play